6431 — Kuangli Bio Tech Holdings Co Share Price
0.000.00%
Last trade - 00:00- TWD1.32bn
- TWD1.62bn
- TWD381.30m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.83 | ||
| Price to Tang. Book | 6.98 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.42 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -28.4% | ||
| Return on Equity | -38.2% | ||
| Operating Margin | -44.86% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 86.97 | 332.63 | 342.16 | 293.37 | 381.3 | n/a | n/a | -2.16% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kuangli Bio Tech Holdings Co Ltd is a Taiwan-based company principally engaged in the processing of optical glass. The Company's main products include smart phone cover glass, tablet cover glass, mobile phone and tablet camera lens, acrylic material plexiglass and other flat panels, as well as open-molded polymethyl methacrylate (PMMA)/polyethylene glycol terephthalate (PET) decoration products. The Company mainly distributes its products in domestic market and to overseas markets, such as Mainland China and Korea.
Directors
- Kuancong Chen CHM
- Youshun Lin FID
- Qinglian Zhang GMG
- Chenxi Chen DRC
- Shuhui Chen DRC
- Rongzhong Fang DRC
- Minzheng Liao DRC
- Shunzhen Qiu DRC
- Jinhe Wang DRC
- Qinghui Zhang DRC
- Mingtang Cai IND
- Jianzhong Chen IND
- Shifang Qiu IND
- Huixian Wang IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 4th, 2012
- Public Since
- December 4th, 2014
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 72,399,000
- Address
- No. 5, TAIPEI, 104
- Web
- http://www.kl-holdings.com/
- Phone
- +886 225178779
- Auditors
- Moore Stephens
Upcoming Events for 6431
Similar to 6431
Chlitina Holding
Taiwan Stock Exchange
Farcent Enterprise Co
Taiwan Stock Exchange
Jourdeness
Taiwan Stock Exchange
KNH Enterprise Co
Taiwan Stock Exchange
Luo Lih Fen Holding Co
Taiwan Stock Exchange
FAQ
What is the Kuangli Bio Tech Holdings Co share price?
As of Today at 21:39 UTC, shares in Kuangli Bio Tech Holdings Co are trading at TWD18.00. This share price information is delayed by 15 minutes.
How has the Kuangli Bio Tech Holdings Co share price performed this year?
Shares in Kuangli Bio Tech Holdings Co last closed at TWD18.00 and the price had moved by +48.15% over the past 365 days. In terms of relative price strength the Kuangli Bio Tech Holdings Co share price has outperformed the FTSE Developed Asia Pacific Index by +49.84% over the past year.
What are the analyst and broker recommendations for Kuangli Bio Tech Holdings Co?
There is no consensus recommendation for this security.
Find out moreWhat is the Kuangli Bio Tech Holdings Co dividend yield?
Kuangli Bio Tech Holdings Co does not currently pay a dividend.
Does Kuangli Bio Tech Holdings Co pay a dividend?
Kuangli Bio Tech Holdings Co does not currently pay a dividend.
When does Kuangli Bio Tech Holdings Co next pay dividends?
Kuangli Bio Tech Holdings Co does not currently pay a dividend.
How do I buy Kuangli Bio Tech Holdings Co shares?
To buy shares in Kuangli Bio Tech Holdings Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Kuangli Bio Tech Holdings Co?
As of the previous close price of TWD18.00, shares in Kuangli Bio Tech Holdings Co had a market capitalisation of TWD1.32bn.
Where are Kuangli Bio Tech Holdings Co shares listed?
Here are the trading details for Kuangli Bio Tech Holdings Co:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 6431
What kind of share is Kuangli Bio Tech Holdings Co?
Based on an overall assessment of its quality, value and momentum Kuangli Bio Tech Holdings Co is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Kuangli Bio Tech Holdings Co share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Kuangli Bio Tech Holdings Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kuangli Bio Tech Holdings Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +5.09%.
As of the last closing price of TWD18.00, shares in Kuangli Bio Tech Holdings Co were trading +3.83% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Kuangli Bio Tech Holdings Co PE Ratio?
The Kuangli Bio Tech Holdings Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD18.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Kuangli Bio Tech Holdings Co?
Kuangli Bio Tech Holdings Co's management team is headed by:
- Kuancong Chen - CHM
- Youshun Lin - FID
- Qinglian Zhang - GMG
- Chenxi Chen - DRC
- Shuhui Chen - DRC
- Rongzhong Fang - DRC
- Minzheng Liao - DRC
- Shunzhen Qiu - DRC
- Jinhe Wang - DRC
- Qinghui Zhang - DRC
- Mingtang Cai - IND
- Jianzhong Chen - IND
- Shifang Qiu - IND
- Huixian Wang - IND